Cited by 105Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisGrowth Hormone and Insulin-like Growth FactorsCytokine Signaling Pathways and Interactions

Induction of macrophage insulin-like growth factor-I expression by the Th2 cytokines IL-4 and IL-13

Open access
Wynes, Murry W, Riches, David W H·2003·The Journal of Immunology

Abstract

Macrophage-derived insulin-like growth factor-I (IGF-I) has long been implicated in the pathogenesis of the interstitial lung disease, idiopathic pulmonary fibrosis, in part, by its ability to 1) stimulate the proliferation and survival of fibroblasts and myofibroblasts and 2) promote collagen matrix synthesis by these cells. However, little is known about the mechanisms that stimulate the expression of IGF-I by macrophages. Previous studies have shown that the development of pulmonary fibrosis is accompanied by enhanced expression of Th2-profile cytokines, especially IL-4, and diminished expression of Th1 cytokines, including IFN-gamma. In addition, in vitro studies have shown that IFN-gamma down-regulates the expression of IGF-I. Thus, the paucity of IFN-gamma in the fibrotic lung may favor increased growth factor production by allowing Th2 cytokines to predominate. In view of these findings, we investigated the hypothesis that Th2 cytokines stimulate the expression of IGF-I by macrophages. Incubation with IL-4 or IL-13 led to concentration- and time-dependent increases in the expression of IGF-I mRNA and the secretion of IGF-I protein by mouse macrophages as a consequence of increased transcription of IGF-I pre-mRNA. Exposure of macrophages to IL-4 in the presence of IFN-gamma inhibited the increase in the expression of IGF-I. Studies using STAT6-deficient macrophages indicated that the increase in IGF-I expression was dependent on STAT6. In addition, the down-regulation of IGF-I expression by IFN-gamma was absent in STAT1-deficient macrophages. Collectively, these findings define a homeostatic mechanism in which Th2 cytokines promote, and Th1 cytokines inhibit, the expression of IGF-I by macrophages.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4049/jimmunol.171.7.3550

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wynes, M. W., & Riches, D. W. H.
Affiliations
National Jewish Health (US)
Venue
The Journal of Immunology
Published
2003-10-01
Volume
171
Issue
7
Pages
3550-3559
ISSN
  • 0022-1767 (ISSN-L)
  • 1550-6606
OpenAlex
W2125584590
Cited by
105
References
64
Citations by year
2026: 1 · 2024: 3 · 2023: 1 · 2021: 2 · 2020: 6 · 2019: 5 · 2018: 9 · 2017: 5 · 2016: 5 · 2015: 7 · 2014: 9 · 2013: 8 · 2012: 2
FWCI
3.80
Type
journal article
Language
en
Open access
Locations
  • The Journal of Immunology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5p50hl056556-05, AI00048)
  • National Heart, Lung, and Blood Institute (HL 55549, R01HL065326, HL 56556, R01HL055549, R01HL068628, HL-68628, HL-65326)
  • National Institute of Allergy and Infectious Diseases (T32-AI00048, T32AI000048)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
Keywords
insulin-like growth factor I, macrophages, Th2 cytokines, IL-4, IL-13, interferon-gamma, STAT6, STAT1, idiopathic pulmonary fibrosis, interstitial lung disease, Th1/Th2 balance
MeSH terms
Animals, Cells, Cultured, DNA-Binding Proteins, Drug Synergism, Gene Expression Regulation, Insulin-Like Growth Factor I, Interferon-gamma, Macrophages, Mice, Inbred BALB C, Mice, Inbred C3H, Transcription, Genetic, Signal Transduction, Trans-Activators, Interleukin-4, Mice, Knockout, Th2 Cells, Interleukin-13, STAT1 Transcription Factor, STAT6 Transcription Factor, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review